Zhou, J.* et al. EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer. Mol. Cancer 24:94 (2025)
Bahrami, E. et al. Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo. Mol. Cancer 22:107 (2023)
Schinke, H.* et al. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer. Mol. Cancer 21:178 (2022)
Müller, S.* et al. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol. Cancer 14:94 (2015)
Müller, S.* et al. Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol. Cancer 14:144 (2015)
Rosemann, M. et al. A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice. Mol. Cancer 13:182 (2014)
Ludyga, N. et al. The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer. Mol. Cancer 12:28 (2013)
Jantscher, F.* ; Pirker, C.* ; Mayer, C.E. ; Berger, W.* & Sutterluety, H.* Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities. Mol. Cancer 10:28 (2011)
Molatore, S. et al. Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors. Mol. Cancer 9:116 (2010)